← Back to all earnings calls

Enanta Pharmaceuticals Inc Q2 FY2022 Earnings Call

Enanta Pharmaceuticals Inc (ENTA)

Earnings Call FY2022 Q2 Call date: 2022-05-09 Concluded

Share

Quarter scorecard

Revenue

$18.72M

-7% YoY

Diluted EPS

$-1.63

Net income

-$33.59M

Revenue · products & services

Royalty $18.72M

License $0

Documents & deck